IL7 and colorectal cancer: In line with these findings are the results recently obtained by Hombach and colleagues, who investigated the potential of genetically engineered, IL-7- and IL-12-over-expressing MSCs to enhance the efficacy of CAR T cells in treating colorectal cancer [28].